DrugShortagePulse: all 353 record reports, page 2 of 2

Every DrugShortagePulse record report, 200 per page. Records 201 to 353: Huons Co., Ltd: Bupivacaine Hydrochloride Injection shortage reverified (unavailable from this maker) to XGen Pharmaceuticals DJB, Inc.: Rocuronium Bromide Injection shortage reverified (available from this maker). Source: openFDA drug shortages endpoint (U.S. Food and Drug Administration drug shortage list).

• Huons Co., Ltd: Bupivacaine Hydrochloride Injection shortage reverified (unavailable from this maker)
• Huons Co., Ltd. (South Korea): Lidocaine Hydrochloride Injection shortage reverified (unavailable from this maker)
• InfoRLife SA: Metronidazole Injection shortage reverified (limited availability from this maker)
• InfoRLife SA: Ropivacaine Hydrochloride Injection shortage update (available from this maker)
• Ipsen Biopharmaceuticals, Inc.: Palovarotene Capsule to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.): Caspofungin Acetate Injection to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.): Daptomycin Injection to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.): Desflurane Liquid for Inhalation to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.): Dexmedetomidine Hydrochloride Injection shortage update (unavailable from this maker)
• Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.): Dexmedetomidine Hydrochloride Injection to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.: Dexmedetomidine Hydrochloride Injection shortage reverified (available from this maker)
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.: Gadobutrol Injection to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.: Gadoterate Meglumine Injection to be discontinued
• Jiangsu Hengrui Pharmaceuticals Co., Ltd.: Oxaliplatin Injection to be discontinued
• Journey Medical Corporation: Sulconazole Nitrate Solution to be discontinued
• Kindos Pharmaceuticals Co. Ltd.: Bupivacaine Hydrochloride Injection shortage update (limited availability from this maker)
• Kindos Pharmaceuticals Co. Ltd.: Bupivacaine Hydrochloride Injection to be discontinued
• Lannett Company, Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage reverified (available from this maker)
• Lannett Company, Inc.: Lisdexamfetamine Dimesylate Capsule shortage update (available from this maker)
• Lannett Company, Inc.: Methylphenidate Hydrochloride Tablet, Extended Release shortage reverified (available from this maker)
• Lifsa Drugs LLC: Isocarboxazid Tablet shortage update (limited availability from this maker)
• Long Grove Pharmaceuticals LLC: Sodium Bicarbonate Injection shortage reverified (available from this maker)
• Lupin Pharmaceuticals, Inc.: Quinapril Hydrochloride Tablet shortage reverified (unavailable from this maker)
• Lupin Pharmaceuticals, Inc.: Rifampin Capsule shortage reverified (available from this maker)
• Medefil, Inc.: Atropine Sulfate Injection shortage reverified (available from this maker)
• Medefil, Inc.: Sterile Water Injection shortage reverified (available from this maker)
• Medexus: Triamcinolone Hexacetonide Injection shortage update (available from this maker)
• Meitheal Pharmaceuticals, Inc.: Azacitidine Injection shortage reverified (available from this maker)
• Meitheal Pharmaceuticals, Inc.: Dexmedetomidine Hydrochloride Injection shortage reverified (available from this maker)
• Meitheal Pharmaceuticals, Inc.: Furosemide Injection shortage reverified (available from this maker)
• Meitheal Pharmaceuticals, Inc.: Liraglutide Injection shortage update (available from this maker)
• Meitheal Pharmaceuticals, Inc.: Rocuronium Bromide Injection shortage reverified (available from this maker)
• Merck Sharp & Dohme LLC: Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection to be discontinued
• Merck Sharp & Dohme LLC: Ivermectin Tablet to be discontinued
• Merck Sharp & Dohme LLC: Molnupiravir Capsule to be discontinued
• Micro Labs LTD: Cromolyn Sodium Concentrate shortage reverified (available from this maker)
• MSN Laboratories Private Limited: Bumetanide Injection shortage resolved
• Mullan Pharmaceutical Inc.: Bumetanide Injection shortage resolved
• Mylan Institutional, a Viatris Company: Dexamethasone Sodium Phosphate Injection shortage reverified (available from this maker)
• Mylan Institutional, a Viatris Company: Dexmedetomidine Hydrochloride Injection shortage reverified (available from this maker)
• Mylan Institutional, a Viatris Company: Etomidate Injection shortage reverified (available from this maker)
• Mylan Institutional, a Viatris Company: Iron Sucrose Injection to be discontinued
• Mylan Institutional, a Viatris Company: Remifentanil Hydrochloride Injection shortage reverified (available from this maker)
• Mylan Institutional, a Viatris Company: Rifampin Injection shortage reverified (unavailable from this maker)
• Mylan Institutional, a Viatris Company: Rocuronium Bromide Injection shortage reverified (available from this maker)
• Mylan Pharmaceuticals Inc., a Viatris Company: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker)
• Mylan Pharmaceuticals Inc., a Viatris Company: Mesalamine Capsule, Extended Release to be discontinued
• Mylan Pharmaceuticals Inc., a Viatris Company: Metformin Hydrochloride Tablet, Extended Release to be discontinued
• Mylan Pharmaceuticals Inc., a Viatris Company: Rivastigmine Film, Extended Release to be discontinued
• Mylan Pharmaceuticals Inc., a Viatris Company: Travoprost Ophthalmic Solution to be discontinued
• Mylan Specialty, a Viatris Company: Cromolyn Sodium Concentrate shortage reverified (available from this maker)
• Nephron Pharmaceuticals Corporation: Albuterol Sulfate Solution shortage resolved
• Nephron Pharmaceuticals Corporation: Sterile Water Injection shortage reverified (limited availability from this maker)
• Novadoz Pharmaceuticals LLC: Lisdexamfetamine Dimesylate Tablet, Chewable shortage reverified (available from this maker)
• Noven Pharmaceuticals, Inc.: Methylphenidate Film, Extended Release shortage reverified (available from this maker)
• Novo Nordisk, Inc.: Liraglutide Injection shortage reverified (limited availability from this maker)
• Novo Nordisk, Inc.: Liraglutide Injection to be discontinued
• Novo Nordisk, Inc.: Semaglutide Tablet to be discontinued
• ONESOURCE SPECIALTY PTE LTD: Bupivacaine Hydrochloride Injection shortage update (available from this maker)
• Oryza Pharmaceuticals Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage reverified (unavailable from this maker)
• Otsuka ICU Medical LLC: Amino Acid Injection shortage reverified (available from this maker)
• Otsuka ICU Medical LLC: Dextrose Monohydrate 10% Injection shortage reverified (unavailable from this maker)
• Otsuka ICU Medical LLC: Dextrose Monohydrate 5% Injection shortage reverified (available from this maker)
• Otsuka ICU Medical LLC: Dextrose Monohydrate 70% Injection shortage reverified (available from this maker)
• Otsuka ICU Medical LLC: Sterile Water Irrigant shortage reverified (unavailable from this maker)
• Padagis US LLC: Activated Charcoal Oral Suspension to be discontinued
• Padagis US LLC: Aspirin Suppository to be discontinued
• Padagis US LLC: Bacitracin Ophthalmic Ointment shortage update (unavailable from this maker)
• Padagis US LLC: Belladonna and Opium Suppository to be discontinued
• Padagis US LLC: Hydrocortisone Acetate Suppository to be discontinued
• Padagis US LLC: Hydromorphone Hydrochloride Suppository to be discontinued
• Padagis US LLC: Morphine Sulfate Suppository to be discontinued
• Padagis US LLC: Podophyllum Resin Topical Tincture to be discontinued
• Par Health, USA LLC: Dexmedetomidine Hydrochloride Injection shortage reverified (unavailable from this maker)
• Par Health, USA LLC: Everolimus Tablet to be discontinued
• Par Health, USA LLC: Felodipine Tablet, Extended Release to be discontinued
• Par Health, USA LLC: Felodipine Tablet, Film Coated, Extended Release to be discontinued
• Par Health, USA LLC: Methylprednisolone Acetate Injection shortage reverified (unavailable from this maker)
• Par Health, USA LLC: Micafungin Sodium Injection to be discontinued
• Pfizer Inc.: Clindamycin Phosphate Injection shortage update (unavailable from this maker)
• Pfizer Inc.: Clindamycin Phosphate Injection to be discontinued
• Pfizer Inc.: Dacomitinib Tablet to be discontinued
• Pfizer Inc.: Dexmedetomidine Hydrochloride Injection shortage update (available from this maker)
• Pfizer Inc.: Disopyramide Phosphate Capsule, Extended Release to be discontinued
• Pfizer Inc.: Lorlatinib Tablet to be discontinued
• Pfizer Inc.: Medroxyprogesterone Acetate Tablet to be discontinued
• Pfizer Inc.: Methylprednisolone Acetate Injection shortage update (limited availability from this maker)
• Pfizer Inc.: Penicillin G Benzathine Injection shortage update (unavailable from this maker)
• pharmaand GmbH (pharma&): Peginterferon alfa-2a Injection shortage resolved
• Piramal Critical Care Inc.: Morphine Sulfate Injection shortage update (available from this maker)
• Piramal Critical Care Inc.: Rocuronium Bromide Injection shortage update (available from this maker)
• Prinston Pharmaceutical, Inc.: Clonazepam Tablet shortage reverified (available from this maker)
• Rhodes Pharmaceuticals L.P.: Lisdexamfetamine Dimesylate Capsule shortage update (limited availability from this maker)
• Rising Pharma Holdings, Inc.: Albuterol Sulfate Solution shortage resolved
• Rising Pharma Holdings, Inc.: Cromolyn Sodium Concentrate shortage reverified (available from this maker)
• Rising Pharma Holdings, Inc.: Flurazepam Hydrochloride Capsule shortage reverified (unavailable from this maker)
• Ritedose Pharmaceuticals, LLC: Albuterol Sulfate Solution shortage resolved
• Rubicon Research Private Limited: Clonazepam Tablet shortage reverified (available from this maker)
• Salix Pharmaceuticals, a division of Bausch Health US, LLC: Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid... to be discontinued
• Sandoz Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage reverified (available from this maker)
• Sandoz Inc.: Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops to be discontinued
• Sandoz Inc.: Clindamycin Phosphate Injection shortage reverified (available from this maker)
• Sandoz Inc.: Rocuronium Bromide Injection shortage reverified (available from this maker)
• Sanofi-Aventis U.S. LLC: Enoxaparin Sodium Injection to be discontinued
• Sanofi-Aventis U.S. LLC: Glyburide Tablet to be discontinued
• Sanofi-Aventis U.S. LLC: Leflunomide Tablet to be discontinued
• Sanofi-Aventis U.S. LLC: Rifampin Injection shortage reverified (unavailable from this maker)
• Sanofi-Aventis U.S. LLC: Rifapentine Tablet, Film Coated shortage resolved
• Solco Healthcare US, LLC: Lisdexamfetamine Dimesylate Capsule shortage reverified (limited availability from this maker)
• Solco Healthcare US, LLC: Quinapril Hydrochloride Tablet shortage reverified (unavailable from this maker)
• Somerset Therapeutics, LLC: Atropine Sulfate Injection shortage reverified (available from this maker)
• Somerset Therapeutics, LLC: Bupivacaine Hydrochloride Injection shortage update (available from this maker)
• Somerset Therapeutics, LLC: Dexamethasone Sodium Phosphate Injection shortage reverified (available from this maker)
• Somerset Therapeutics, LLC: Dexmedetomidine Hydrochloride Injection shortage reverified (available from this maker)
• Somerset Therapeutics, LLC: Ropivacaine Hydrochloride Injection shortage reverified (available from this maker)
• Somerset Therapeutics, LLC: Sodium Acetate Injection shortage reverified (available from this maker)
• SpecGx LLC: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage update (available from this maker)
• SpecGx LLC: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker)
• Spectra Medical Devices, LLC: Lidocaine Hydrochloride Injection shortage reverified (unavailable from this maker)
• SteriMax, Inc.: Cefotaxime Sodium Powder, for Solution shortage update (available from this maker)
• SteriMax, Inc.: Ifosfamide Injection new FDA shortage listing (available from this maker)
• Sun Pharmaceutical Industries, Inc.: Lisdexamfetamine Dimesylate Capsule shortage update (limited availability from this maker)
• Sun Pharmaceutical Industries, Inc.: Lisdexamfetamine Dimesylate Tablet, Chewable shortage update (available from this maker)
• Sun Pharmaceutical Industries, Inc.: Methylphenidate Hydrochloride Tablet, Extended Release shortage update (unavailable from this maker)
• Sun Pharmaceutical Industries, Inc.: Technetium TC-99M Pyrophosphate Kit Injection shortage reverified (unavailable from this maker)
• Sunrise Pharmaceutical, Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage reverified (available from this maker)
• Takeda Pharmaceuticals USA Inc.: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker)
• Takeda Pharmaceuticals USA Inc.: Lisdexamfetamine Dimesylate Tablet, Chewable shortage reverified (available from this maker)
• Takeda Pharmaceuticals USA Inc.: Mesalamine Capsule, Extended Release to be discontinued
• Teva Pharmaceuticals USA, Inc.: Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate... shortage update (available from this maker)
• Teva Pharmaceuticals USA, Inc.: Azacitidine Injection shortage reverified (unavailable from this maker)
• Teva Pharmaceuticals USA, Inc.: Carboplatin Injection shortage reverified (unavailable from this maker)
• Teva Pharmaceuticals USA, Inc.: Clonazepam Tablet shortage reverified (available from this maker)
• Teva Pharmaceuticals USA, Inc.: Diclofenac Sodium Tablet, Delayed Release to be discontinued
• Teva Pharmaceuticals USA, Inc.: Doxycycline Hyclate Tablet, Delayed Release to be discontinued
• Teva Pharmaceuticals USA, Inc.: Fluocinonide Ointment to be discontinued
• Teva Pharmaceuticals USA, Inc.: Hydromorphone Hydrochloride Injection shortage reverified (available from this maker)
• Teva Pharmaceuticals USA, Inc.: Hydroxocobalamin Injection shortage reverified (unavailable from this maker)
• Teva Pharmaceuticals USA, Inc.: Liraglutide Injection to be discontinued
• Teva Pharmaceuticals USA, Inc.: Lisdexamfetamine Dimesylate Capsule shortage reverified (available from this maker)
• Teva Pharmaceuticals USA, Inc.: Methotrexate Sodium Injection shortage update (limited availability from this maker)
• Teva Pharmaceuticals USA, Inc.: Methylphenidate Hydrochloride Tablet, Extended Release shortage update (available from this maker)
• Teva Pharmaceuticals USA, Inc.: Metoprolol Succinate Tablet, Extended Release to be discontinued
• Teva Pharmaceuticals USA, Inc.: Streptozocin Powder, For Solution shortage reverified (unavailable from this maker)
• Teyro Labs: Carboplatin Injection new FDA shortage listing (available from this maker)
• Teyro Labs: Carboplatin Injection to be discontinued
• Trigen Laboratories, LLC: Methylphenidate Hydrochloride Tablet, Extended Release shortage reverified (limited availability from this maker)
• Vantive US Healthcare LLC: Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate... to be discontinued
• Vertical Pharmaceuticals, LLC: Methylphenidate Hydrochloride Tablet, Extended Release shortage reverified (available from this maker)
• ViiV Healthcare Company: Lamivudine Tablet to be discontinued
• WG Critical Care: Midazolam Hydrochloride Injection shortage reverified (available from this maker)
• XGen Pharmaceuticals DJB, Inc.: Promethazine Hydrochloride Injection shortage reverified (available from this maker)
• XGen Pharmaceuticals DJB, Inc.: Rocuronium Bromide Injection shortage reverified (available from this maker)

Browse DrugShortagePulse by category and location · Search and filter DrugShortagePulse